GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Abbreviated name: BNP
Synonyms: BNP(1-32) | BNP-32 | brain natriuretic peptide 32 | Natrecor®
brain natriuretic peptide is an approved drug (FDA (2001))
Compound class:
Endogenous peptide in human, mouse or rat
Comment: Nesiritide is the recombinant form of human brain natriuretic peptide.
Species: Human
View more information in the IUPHAR Pharmacology Education Project: brain natriuretic peptide |
| Bioactivity Comments |
| There appears to be no publicly available bioactivity data for this drug at its human molecular target. |
| Natural/Endogenous Targets | ||
|
||
| Selectivity at catalytic receptors | ||||||||||||||||||||||||||||||||||
| Key to terms and symbols | Click column headers to sort | |||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||
| Additional information and targets (data relate to human unless otherwise stated) | ||
| Description | Data | Reference |
| Potency order at Guanylyl cyclase-A | atrial natriuretic peptide (NPPA, P01160) ≥ brain natriuretic peptide (NPPB, P16860) >> C-type natriuretic peptide (NPPC, P23582) | 2 |
| Potency order at Guanylyl cyclase-B | C-type natriuretic peptide (NPPC, P23582) >> atrial natriuretic peptide (NPPA, P01160) >> brain natriuretic peptide (NPPB, P16860) | 2 |
| Potency order at natriuretic peptide receptor 3 | atrial natriuretic peptide (NPPA, P01160) > C-type natriuretic peptide (NPPC, P23582) ≥ brain natriuretic peptide (NPPB, P16860) | 2 |